ChZPSN-Profnastil PAO
MOEX:PRFN
ChZPSN-Profnastil PAO
MOEX:PRFN
Price:
4.482
RUB
-2.14%
Market Closed
Market Cap:
₽3.8B
Balance Sheet
Balance Sheet Decomposition
ChZPSN-Profnastil PAO
ChZPSN-Profnastil PAO
Balance Sheet Decomposition is not available for
ChZPSN-Profnastil PAO
ChZPSN-Profnastil PAO
Balance Sheet
ChZPSN-Profnastil PAO
ChZPSN-Profnastil PAO
Currency: RUB
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
10
|
19
|
35
|
143
|
24
|
9
|
2
|
26
|
51
|
23
|
21
|
65
|
71
|
1 349
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
23
|
21
|
65
|
71
|
1 349
|
|
| Cash Equivalents |
10
|
19
|
35
|
143
|
24
|
9
|
2
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
20
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
221
|
160
|
234
|
273
|
451
|
947
|
800
|
680
|
516
|
842
|
447
|
160
|
152
|
393
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
255
|
202
|
125
|
92
|
9
|
289
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
261
|
640
|
322
|
67
|
142
|
103
|
|
| Inventory |
670
|
458
|
838
|
678
|
819
|
949
|
734
|
675
|
739
|
911
|
612
|
253
|
932
|
878
|
|
| Other Current Assets |
8
|
36
|
0
|
0
|
0
|
0
|
0
|
0
|
494
|
820
|
1 247
|
2 024
|
1 655
|
2 346
|
|
| Total Current Assets |
929
|
674
|
1 113
|
1 094
|
1 294
|
1 905
|
1 537
|
1 381
|
1 800
|
2 595
|
2 327
|
2 501
|
2 809
|
4 966
|
|
| PP&E Net |
841
|
1 535
|
1 494
|
1 318
|
1 906
|
1 322
|
1 537
|
1 398
|
1 560
|
1 565
|
1 915
|
1 962
|
1 927
|
1 968
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 560
|
1 565
|
1 915
|
1 962
|
1 927
|
1 968
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 380
|
746
|
681
|
703
|
742
|
697
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
58
|
0
|
0
|
0
|
0
|
0
|
40
|
0
|
0
|
|
| Long-Term Investments |
2
|
9
|
10
|
9 442
|
9 376
|
9 318
|
9 318
|
9 320
|
9 365
|
0
|
0
|
0
|
0
|
102
|
|
| Other Long-Term Assets |
97
|
117
|
68
|
75
|
107
|
23
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1 870
N/A
|
2 336
+25%
|
2 685
+15%
|
11 929
+344%
|
12 707
+7%
|
12 627
-1%
|
12 392
-2%
|
12 100
-2%
|
12 727
+5%
|
4 161
-67%
|
4 243
+2%
|
4 506
+6%
|
4 737
+5%
|
7 035
+49%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
902
|
846
|
1 066
|
1 591
|
1 177
|
832
|
264
|
223
|
418
|
388
|
861
|
1 131
|
849
|
3 513
|
|
| Accrued Liabilities |
4
|
3
|
16
|
16
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
598
|
454
|
459
|
0
|
710
|
915
|
1 060
|
758
|
834
|
1 005
|
731
|
294
|
459
|
764
|
|
| Other Current Liabilities |
4
|
3
|
1
|
3
|
3
|
37
|
243
|
226
|
215
|
552
|
497
|
713
|
797
|
355
|
|
| Total Current Liabilities |
1 508
|
1 305
|
1 542
|
1 610
|
1 904
|
1 784
|
1 567
|
1 207
|
1 467
|
1 944
|
2 089
|
2 138
|
2 105
|
4 633
|
|
| Long-Term Debt |
70
|
3
|
76
|
0
|
0
|
0
|
0
|
134
|
493
|
743
|
505
|
501
|
502
|
2
|
|
| Deferred Income Tax |
32
|
51
|
69
|
18
|
36
|
116
|
89
|
84
|
49
|
31
|
28
|
45
|
44
|
16
|
|
| Other Liabilities |
0
|
633
|
598
|
528
|
530
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1 610
N/A
|
1 992
+24%
|
2 285
+15%
|
2 156
-6%
|
2 471
+15%
|
1 900
-23%
|
1 656
-13%
|
1 426
-14%
|
2 010
+41%
|
2 718
+35%
|
2 623
-3%
|
2 684
+2%
|
2 651
-1%
|
4 651
+75%
|
|
| Equity | |||||||||||||||
| Common Stock |
84
|
84
|
84
|
84
|
84
|
84
|
84
|
84
|
84
|
84
|
84
|
84
|
84
|
84
|
|
| Retained Earnings |
160
|
244
|
300
|
9 672
|
10 137
|
10 644
|
9 441
|
9 463
|
9 505
|
153
|
329
|
532
|
796
|
1 094
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
1 211
|
1 127
|
1 127
|
1 206
|
1 206
|
1 206
|
1 206
|
1 206
|
|
| Other Equity |
16
|
16
|
16
|
16
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
260
N/A
|
344
+32%
|
400
+16%
|
9 772
+2 343%
|
10 237
+5%
|
10 728
+5%
|
10 736
+0%
|
10 674
-1%
|
10 716
+0%
|
1 443
-87%
|
1 619
+12%
|
1 822
+13%
|
2 086
+14%
|
2 384
+14%
|
|
| Total Liabilities & Equity |
1 870
N/A
|
2 336
+25%
|
2 685
+15%
|
11 929
+344%
|
12 707
+7%
|
12 627
-1%
|
12 392
-2%
|
12 100
-2%
|
12 727
+5%
|
4 161
-67%
|
4 243
+2%
|
4 506
+6%
|
4 737
+5%
|
7 035
+49%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
838
|
838
|
838
|
838
|
838
|
838
|
838
|
838
|
838
|
838
|
838
|
838
|
838
|
838
|
|
Switch to:
Switch to:
See Also
Discover More
